http://tan.sagepub.com/content/6/4/249.abstract?etoc
Abstract
Central nervous system inflammatory
demyelinating disease can affect patients across the life span.
Consensus definitions
and criteria of all of the different acquired
demyelinating diseases that fall on this spectrum have magnetic
resonance imaging
criteria. The advances of both neuroimaging
techniques and important discoveries in immunology have produced an
improved understanding
of these conditions and classification.
Neuroimaging plays a central role in the accurate diagnosis, prognosis,
disease monitoring
and research efforts that are being undertaken in
this disease. This review focuses on the imaging spectrum of acquired
demyelinating
disease.
No comments:
Post a Comment